Pitcher GS, Sen I, Mendes BC, Shuja F, DeMartino RR, Bower TC, Kalra M, Harmsen WS, Colglazier JJ. 30-year Single Center Experience with Arterial Thoracic Outlet Syndrome.
J Vasc Surg 2022;
76:523-530. [PMID:
35378247 DOI:
10.1016/j.jvs.2022.03.870]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 03/27/2022] [Indexed: 11/18/2022]
Abstract
OBJECTIVES
Arterial thoracic outlet syndrome (ATOS) is rare. We present our 30-year experience with management of ATOS at a high-volume referral center.
METHODS
A retrospective review of all patients who underwent primary operative treatment for ATOS from 1988 to 2018 was performed. ATOS was defined as subclavian artery pathology caused by extrinsic compression from a bony abnormality within the thoracic outlet.
RESULTS
Forty-one patients (forty-five limbs) underwent surgical treatment for ATOS with a median age of 46 years (IQR 34-58 years). Chronic symptoms (>6 weeks) were present in 31 patients (69%). Thirteen patients (29%) presented with acute limb ischemia (ALI) requiring urgent brachial artery thromboembolectomy (BAT) in nine and catheter-directed thrombolysis and thrombectomy (CDT) in four. All patients underwent thoracic outlet decompression. Thirty-one patients (69%) required subclavian artery reconstruction. There were no perioperative deaths and only one major adverse limb event. Patients with ALI had staged thoracic outlet decompression after initial BAT or CDT at a median of 23 days (IQR 11-140 days). Eight patients (62%) whose initial presentation was ALI had recurrent thromboembolic events prior to thoracic outlet decompression subsequently requiring ten additional BATs and one CDT. The cumulative probability of recurrent embolization at 14 days, 30 days and 90 days was 8.33% (CI 1.28-54.42%), 16.67% (CI 4.70-59.06%) and 33.33% (14.98-74.20%) respectively. Thirty-two patients had follow-up at a median of 13 months (IQR 5-36). Subclavian artery/graft primary and secondary patency were 87% and 90% respectively at 5 years by Kaplan Meier analysis. Five (14%) had chronic upper extremity pain and five (14%) had persistent weakness. Preoperative forearm or hand pain and brachial artery occlusion were associated with chronic pain (P = .04 and P = .03) and weakness (P = .03 and P = .02). Eleven patients who presented with ALI had follow-up after thoracic outlet decompression at a median of 6 months (IQR 5-14), including nine (82%) who were discharged on oral anticoagulation. Anticoagulation had no effect on patency (P = 1.0) or chronic symptoms (P = .93).
CONCLUSIONS
The presentation of ATOS is diverse and diagnosis can be delayed. Preoperative upper extremity pain and brachial artery occlusion in the setting of ALI were associated with chronic pain and weakness following thoracic outlet decompression. Delayed thoracic outlet decompression was associated with an increased risk of recurrent thromboembolic events in patients who presented with ALI. An early and accurate diagnosis of ATOS is necessary to reduce morbidity and optimize outcomes.
Collapse